Stockreport

Pacira BioSciences: Targeting Sales >$1bn By 2025 Despite New Competitive Threat [Seeking Alpha]

Heron Therapeutics, Inc.  (HRTX) 
Last heron therapeutics, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: herontherapeutics.gcs-web.com/investor-home
PDF Summary Long-acting, local analgesic exparel earned Pacira $400m in revenues in 2019. Pacira has paid $120m to acquire MyoScience with up to $100m more in milestones pay [Read more]